Why the study?
Are there differences in the AT1 receptor gene between patients with aldosterone-producing adenomas and normal subjects?
Are there differences in the AT1 receptor gene between patients with aldosterone-producing adenomas and normal subjects?
There are no significant mutations or polymorphisms in the coding region of the AT1 receptor gene associated with aldosterone-producing adenomas.
No AT1 receptor coding variants linked to aldosterone-producing adenomas; leaves open non-coding regions or other genes in pathogenesis.
In patients with primary aldosteronism due to angiotensin-responsive and angiotensin-unresponsive aldosterone-producing adenomas, no differences in the coding region of the angiotensin II type 1 (AT1) receptor gene were observed compared to normal subjects in peripheral blood leucocyte DNA. 2. Furthermore, no differences in the AT1 receptor gene were observed in DNA extracted from tumour tissue of either subgroup. 3. Genotypic and allelic frequencies for an RFLP detected in the coding region of the AT1 receptor gene were not significantly different between normal subjects and patients with aldosterone-producing adenomas as a group, nor between normal subjects and patients of either subgroup when compared with each other. 4. In those patients heterozygous in peripheral blood at the RFLP site, tumour DNA showed the same allelic pattern. 5. In patients with aldosterone-producing adenomas either responsive or unresponsive to the renin-angiotensin system, no differences were detected using SSCP analysis in the coding region of the AT1 receptor gene in peripheral blood or tumour tissue.
No takes yet. Share an insight, caveat, or question.
Klemm et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: